Gastrointestinal Cancer,Liver Cancer AFP Trajectories and Outcomes in Unresectable HCC With Atez/Bev Therapy Jul 19, 2023
Gastrointestinal Cancer,Liver Cancer KEYNOTE-240 Trail Assessed Pembrolizumab in Patients with Advanced Liver Cancer Apr 21, 2023
Gastrointestinal Cancer,Liver Cancer COSMIC-312: Evaluated Cabozantinib and Atezolizumab in Treatment-Naive Advanced HCC Apr 21, 2023
Gastrointestinal Cancer,Liver Cancer CheckMate-459 Study: Comparing Nivolumab to Sorafenib in Liver Cancer Apr 21, 2023
Gastrointestinal Cancer,Liver Cancer Impact of ADAs on uHCC Treatment in HIMALAYA Phase 3 Study Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer HRQoL Impact of Tislelizumab vs. Sorafenib in First-line uHCC: RATIONALE-301 Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer LEAP-002 Study: Lenvatinib+Pembrolizumab vs Lenvatinib+Placebo in aHCC HRQoL Comparison Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer Phase 3 Trial: Pembrolizumab vs. Placebo for Second-Line HCC Treatment in Asian Patients Mar 10, 2023
